Estos tipos son sólidos. Todo es transparente, los informes llegaban con regularidad y hacen exactamente lo que dicen. Sin información oculta, lo comprobé
NewAmsterdam Pharma Stock: Obicetrapib More Than Another LDL-Lowering Pill (NASDAQ:NAMS) | Seeking AlphaIchor Holdings: Waiting For Proof, Not A Better Price (NASDAQ:ICHR) | Seeking AlphaNoah Holdings -Strong 2Q Expected (NYSE:NOAH) | Seeking AlphaJPMorgan Chase Stock: Top Bank For Earning Power And Fortress Balance Sheet (NYSE:JPM) | Seeking AlphaCarpenter Technology Stock: From Strong Buy To Sell After A 78% Rally (NYSE:CRS) | Seeking Alpha

economy, business and finance
This is the forum for daily political discussion on Seeking Alpha. A new version is published every market day. Please don't leave political comments on other articles or posts on the site. The comments below are not regulated with the same rigor as the rest of the site, and this is an 'enter at .…

business information
A strong balance sheet supports NAMS through key clinical readouts and potential U.S. launch, mitigating near-term financing risk despite ongoing pre-commercial status. I think NewAmsterdam Pharma (NAMS) is in a promising position because I believe obicetrapib is currently being viewed as just ...
No hay artículos todavía
Los artículos aparecerán aquí una vez que se publiquen.
